Eosinophilic Asthma Resource Centre

Welcome, this website is intended for all international healthcare professionals. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Optimizing Targeted Therapy In Uncontrolled Eosinophilic Asthma

Interactive Patient Case

In this interactive case study, you will have the opportunity to explore a specific patient case in depth and learn more about monitoring patient responses to IL-5 targeted therapies for eosinophilic asthma 

Learning objectives

Following the review of this interactive case study, you should be able to:

  • Discuss the selection and initiation of an optimal IL-5 targeted therapy for treating uncontrolled eosinophilic asthma
  • Evaluate the efficacy, safety, and tolerability of anti-IL-5 biologicals
  • Identify the criteria used to monitor patient responses to IL-5 targeted therapy

New interactive patient cases coming soon

  • Switching targeted therapy in eosinophilic asthma: anti-IgE or anti-IL-5?

If you would like to be informed when the new content is available, please sign up for the e-alert

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre.

Search this site

New EAACI 2017 Conference Highlights

Featured Video Presentation

Share